Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**5'-Deoxy-5'-(Methylthio)-Tubercidin** is a synthetic small molecule analog of tubercidin. It features a methylthio group at the 5’ position of the ribose moiety. This compound acts as an inhibitor of enzymes involved in nucleoside metabolism—specifically targeting enzymes such as methylthioadenosine phosphorylase and nucleosidases. It has been used primarily as a biochemical tool to study enzyme specificity and kinetics in purine metabolism pathways and is not approved for therapeutic use. Its mechanism involves competitive inhibition at the active site of these enzymes by mimicking natural substrates[2][8]. The compound is mainly used in research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5'-Deoxy-5'-(Methylthio)-Tubercidin.